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After 4 months the patient achieved significant weight loss and 
reduction of hemoglobin A1c levels. Therapeutic gains were 
substantial, with a reduction in affective symptomatology, 
somatic complaints, and sleep problems. Notable 
improvements were observed in all dimensions of well-being, 
including those that were not specifically addressed by the 
intervention. Conclusions: WBT may have a role in 
promoting lifestyle changes. WBT may contribute to improved 
health attitudes and behaviors as a result of its effect on 
reducing stress and related psychological distress. 
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Sleep and sleep deprivation modify brain plasticity in opposite 
manner. The most advanced technologies (brain imaging and 
supermicroscopic images) have recently allowed to discover 
the morphological changes in different brain areas during sleep 
and sleep deprivation. These studies have also shown that 
cortisol and melatonin are the two most important hormones 
involved in these plastic changes of the brain. In the 
presentation will be discussed the functional relationship 
between the brain morphological changes and the vulnerability 
to psychopathology.  
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Background: It is known and widely recognized that the 
reduction or discontinuation of Selective Serotonin Reuptake 
Inhibitors (SSRIs) and selective serotonin and noradrenaline 
reuptake inhibitors (SNRIs) may induce withdrawal. In 2015, 
Chouinard and Chouinard proposed a new literature-based 
classification by formulating specific diagnostic criteria for 
three different SSRI/SNRI withdrawal syndromes: new 
withdrawal symptoms, rebound symptom withdrawal, 
persistent post-withdrawal disorders. A semi-structured 
clinical interview, the Diagnostic Clinical Interview for Drug 
Withdrawal 1 - New Symptoms of SSRI and SNRI (DID-W1), 
was developed for identifying and differentiating such 
syndromes. The present study was conducted to test the inter-
rater reliability of the DID-W1 and the Discontinuation-
Emergent Signs Checklist (DESS). Methods: A total of 47 
subjects with a history of SSRI or SNRI reduction or 
discontinuation were enrolled through the web and assessed by 
two independent raters with the DID-W1 interview. The inter-
rater reliability was measured by percent agreement, Cohen's 
kappa, and the squared correlation coefficient. Results: The 
percent agreement for the whole interview was 93.6%, the 
Cohen's kappa .871 (95%CI  .73-1.00), the squared correlation 
coefficient .75. Similar results were found analysing each 
module of the DID-W1. Conclusions: Kappa values and the 
squared coefficient showed excellent inter-rater agreement. 
The DID-W1 may help diagnosing the clinical conditions 
related to SSRI and SNRI discontinuation and differentiating 
withdrawal syndromes from relapse and recurrence of the 
original illness. Thus, it may be considered as a resource for 
clinical assessment and treatment optimization. 
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Background: Psoriasis is a complex and chronic 
inflammatory skin disorder. The mechanisms underlying this 
immune-mediated disease are not clear, but some evidence 
indicates that specific personality features and symptom 
patterns may play an important role in the development and 
clinical presentation of the disorder and influence the quality 
of patients’ lives. This study aimed at evaluating the 
associations among the quality of life, illness severity, 
psychiatric symptoms and personality patterns in patients with 
psoriasis treated with biological or topical therapy. Methods: 
Fifty psoriatic patients were evaluated with self-report 
measures: the Symptom Checklist-90-R (SCL-90R) and the 
Psoriasis Index of Quality of Life (PSORIQoL). Their 
personality and psychological functioning were assessed by 
external raters using the Shedler-Westen Assessment 
Procedure (SWAP-200) applied to the Clinical Diagnostic 
Interviews (CDI). Finally, the severity and the area of psoriatic 
lesions were evaluated by dermatologists with the Psoriasis 
Area Severity Index (PASI). Results: Significant differences 
between the groups (biological vs topical therapy) were found 
in PASI scores: patients assigned to biological therapy showed 
lower levels of illness severity. No differences were found in 
PSORIQoL scores. The quality of life was negatively 
associated with various dimensions of SCL-90R and with 
borderline (r = .39; p< .01), dependent (r = .41; p< .01) and 
avoidant (r = .35; p< .05) personality styles/disorders; 
conversely, it did not relate to PASI. Conclusions: The results 
seem to suggest that the quality of life in psoriatic patients is 
more influenced by personality characteristics and psychiatric 
symptoms than by the severity of psoriatic lesions.  
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